Peptide-based radiopharmaceuticals: Futu
β
S.M. Okarvi
π
Article
π
2004
π
John Wiley and Sons
π
English
β 575 KB
## Abstract An Erratum has been published for this article in Medicinal Research Reviews 2004;24:685β686. Small synthetic receptorβbinding peptides are the agents of choice for diagnostic imaging and radiotherapy of cancers due to their favorable pharmacokinetics. Molecular modification techniques